European researchers have found that men with low free testosterone levels – but normal total testosterone levels – often have symptoms of hypogonadism.
Low testosterone appears to be a marker for several cardiovascular risk factors, but there appears to be no direct association between testosterone levels and atherosclerosis (hardening of the arteries), individual cardiac events, or death.
In the midst of controversy, four new studies have found no link between testosterone therapy and cardiovascular risk.
On March 3, 2015, the U.S. Food and Drug Administration (FDA) announced that new labeling requirements for FDA-approved testosterone products.
A team of researchers from the University of North Carolina has compared the prevalence of low testosterone in men with erectile dysfunction (ED) and men with Peyronie’s disease (PD) and found no significant differences.
Taking statins does not appear to increase the risk of gonadal or sexual dysfunction, according to a team of American researchers.